Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jin-Mu Yi

Biographic Data

ID7270819
NAMEJin-Mu Yi
GIVEN NAMESJin-Mu
FAMILY NAMEYi
SIGNATUREYI J
AFFILIATIONSWonkwang University
ORCID0000-0002-8717-3953
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2002
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Bojungikki-tang enhances M1-like macrophage activation and promotes antitumor responses through IFN-γ co-stimulation

    Open Access•Jin-Mu Yi, Se Won et al.•ARTICLE•Journal of Ethnopharmacology•2026

    ETHNOPHARMACOLOGICAL RELEVANCE: Bojungikki-tang (BJIKT), a traditional East-Asian multi-herbal prescription known for enhancing immune function, treating chronic fatigue, and improving general vitality, is often prescribed for conditions related to immune deficiency or cancer-related fatigue. However, its cellular mechanisms remain poorly defined. AIM OF THE STUDY: To determine whether BJIKT promotes M1-like macrophage activation and exerts antit…

  • Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot …

    Open Access•Mi Mi Ko, Mi-Kyung Jeong et al.•ARTICLE•International Journal of…•2023

    Cancer immunotherapy with immune checkpoint inhibitors (ICIs) is a major treatment option for several types of cancer, including non-small cell lung cancer (NSCLC). The proposed study aims to investigate the safety and efficacy of Bojungikki-tang (BJIKT) therapy (an herbal medicine) in patients with advanced NSCLC treated with ICIs. This multicenter, randomized, placebo-controlled pilot study will be performed at three academic hospitals. Thirty …

  • Aqueous extract of Forsythia viridissima fruits: Acute oral toxicity and genotoxicity studies

    Open Access•Sarah Shin, Jin-Mu Yi et al.•ARTICLE•Journal of Ethnopharmacology•2020

    We found that EFVF is safe with regard to acute toxicity in rats as well as genotoxicity such as mutagenesis or clastogenesis under the present experimental conditions. These results might support the safety of EFVF as a potential therapeutic material for the traditional use or pharmaceutical development

  • Inhibitory effects of Okbyungpoong-Gamhmi on anaphylactic responses

    Open Access•Seung-Heon Hong, Seung‐Heon Hong et al.•ARTICLE•Journal of Ethnopharmacology•2005

  • Inhibitory effect of Sejin-Eum I/II on nicotine- and cigarette extract-induced cytotoxicity in human lung fibroblast

    Open Access•Jong-Sik Jin, Jong‐Sik Jin et al.•ARTICLE•Journal of Ethnopharmacology•2003

  • Induction of apoptosis by Paljin-Hangahmdan on human leukemia cells

    Open Access•Jin-Mu Yi, Mi-Sun Kim et al.•ARTICLE•Journal of Ethnopharmacology•2003

  • Effect of Acanthopanax senticosus stem on mast cell-dependent anaphylaxis

    Open Access•Jin-Mu Yi, Seung-Heon Hong et al.•ARTICLE•Journal of Ethnopharmacology•2002

No prominent works on this page.

  • Effect of Acanthopanax senticosus stem on mast cell-dependent anaphylaxis

    Open Access•Jin-Mu Yi, Seung-Heon Hong et al.•ARTICLE•Journal of Ethnopharmacology•2002

  • Inhibitory effect of Sejin-Eum I/II on nicotine- and cigarette extract-induced cytotoxicity in human lung fibroblast

    Open Access•Jong-Sik Jin, Jong‐Sik Jin et al.•ARTICLE•Journal of Ethnopharmacology•2003

  • Induction of apoptosis by Paljin-Hangahmdan on human leukemia cells

    Open Access•Jin-Mu Yi, Mi-Sun Kim et al.•ARTICLE•Journal of Ethnopharmacology•2003

  • Inhibitory effects of Okbyungpoong-Gamhmi on anaphylactic responses

    Open Access•Seung-Heon Hong, Seung‐Heon Hong et al.•ARTICLE•Journal of Ethnopharmacology•2005

  • Aqueous extract of Forsythia viridissima fruits: Acute oral toxicity and genotoxicity studies

    Open Access•Sarah Shin, Jin-Mu Yi et al.•ARTICLE•Journal of Ethnopharmacology•2020

    We found that EFVF is safe with regard to acute toxicity in rats as well as genotoxicity such as mutagenesis or clastogenesis under the present experimental conditions. These results might support the safety of EFVF as a potential therapeutic material for the traditional use or pharmaceutical development

  • Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot …

    Open Access•Mi Mi Ko, Mi-Kyung Jeong et al.•ARTICLE•International Journal of…•2023

    Cancer immunotherapy with immune checkpoint inhibitors (ICIs) is a major treatment option for several types of cancer, including non-small cell lung cancer (NSCLC). The proposed study aims to investigate the safety and efficacy of Bojungikki-tang (BJIKT) therapy (an herbal medicine) in patients with advanced NSCLC treated with ICIs. This multicenter, randomized, placebo-controlled pilot study will be performed at three academic hospitals. Thirty …

  • Bojungikki-tang enhances M1-like macrophage activation and promotes antitumor responses through IFN-γ co-stimulation

    Open Access•Jin-Mu Yi, Se Won et al.•ARTICLE•Journal of Ethnopharmacology•2026

    ETHNOPHARMACOLOGICAL RELEVANCE: Bojungikki-tang (BJIKT), a traditional East-Asian multi-herbal prescription known for enhancing immune function, treating chronic fatigue, and improving general vitality, is often prescribed for conditions related to immune deficiency or cancer-related fatigue. However, its cellular mechanisms remain poorly defined. AIM OF THE STUDY: To determine whether BJIKT promotes M1-like macrophage activation and exerts antit…

Medicine (5 works) · Internal Medicine (4 works) · Biological activity (3 works) · Immunology (3 works) · In vitro (3 works) · Pathology (3 works) · Pharmacology (3 works) · Traditional medicine (3 works) · Allergy (2 works) · Alternative medicine (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae